Steven Stein
Patrimonio netto: 8 M $ in data 31/05/2026
Patrimonio netto: 8 M $ in data 31/05/2026
Steven H. Stein ricopre la posizione di Chief Medical Officer & Executive Vice President alla Incyte Corp. Il Dr. Stein è anche nel consiglio di amministrazione di Kura Oncology, Inc. Nella sua carriera passata il Dr. Stein è stato vicepresidente di Oncologia globale presso GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs presso Novartis Oncology, Inc. e Senior VP-US Clinical Development & Medical Affair presso Novartis Pharmaceuticals Corp. Il Dr. Stein ha ricevuto un dottorato dall'Università del Witwatersrand.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
INCYTE CORPORATION 0,04% | 06/05/2026 | 78.327 ( 0,04% ) | 8 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INCYTE CORPORATION | Direttore Tecnico/Scientifico/R&S | 02/03/2015 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consulente / Consigliere | - |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| REPARE THERAPEUTICS INC. | Direttore/Membro del Consiglio | 28/01/2026 |
| THESEUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 14/02/2024 |
| KURA ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/05/2023 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/02/2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/02/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Repare Therapeutics, Inc.
Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale